Evidence map›Paper›PMID 34734349›Full record

Observational studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2022

Developing an iOS application that uses machine learning for the automated diagnosis of blepharoptosis.

Hitoshi Tabuchi, Daisuke Nagasato, Hiroki Masumoto, Mao Tanabe, Naofumi Ishitobi, Hiroki Ochi, Yoshie Shimizu, Yoshiaki Kiuchi

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Hitoshi TabuchiDepartment of Technology and Design Thinking for Medicine, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-9098-0430
Daisuke NagasatoDepartment of Technology and Design Thinking for Medicine, Hiroshima University, Hiroshima, Japan. d.nagasato@tsukazaki-eye.net.ORCID http://orcid.org/0000-0003-3956-9352
Hiroki MasumotoDepartment of Technology and Design Thinking for Medicine, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-5413-8844
Mao TanabeDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, 68-1 Waku, Aboshi-ku, Himeji City, Hyogo, 671-1227, Japan.
Naofumi IshitobiDepartment of Technology and Design Thinking for Medicine, Hiroshima University, Hiroshima, Japan.
Hiroki OchiDepartment of Medicine, Hiroshima University, Hiroshima, Japan.
Yoshie ShimizuDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, 68-1 Waku, Aboshi-ku, Himeji City, Hyogo, 671-1227, Japan.
Yoshiaki KiuchiDepartment of Ophthalmology and Visual Sciences, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0003-1915-1864
Hiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the performance of artificial intelligence in the automated classification of images taken with a tablet device of patients with blepharoptosis and subjects with normal eyelid.

methodsThis is a prospective and observational study. A total of 1276 eyelid images (624 images from 347 blepharoptosis cases and 652 images from 367 normal controls) from 606 participants were analyzed. In order to obtain a sufficient number of images for analysis, 1 to 4 eyelid images were obtained from each participant. We developed a model by fully retraining the pre-trained MobileNetV2 convolutional neural network. Subsequently, we verified whether the automatic diagnosis of blepharoptosis was possible using the images. In addition, we visualized how the model captured the features of the test data with Score-CAM. k-fold cross-validation (k = 5) was adopted for splitting the training and validation. Sensitivity, specificity, and the area under the curve (AUC) of the receiver operating characteristic curve for detecting blepharoptosis were examined.

resultsWe found the model had a sensitivity of 83.0% (95% confidence interval [CI], 79.8-85.9) and a specificity of 82.5% (95% CI, 79.4-85.4). The accuracy of the validation data was 82.8%, and the AUC was 0.900 (95% CI, 0.882-0.917).

conclusionArtificial intelligence was able to classify with high accuracy images of blepharoptosis and normal eyelids taken using a tablet device. Thus, the diagnosis of blepharoptosis with a tablet device is possible at a high level of accuracy.

trial registrationDate of registration: 2021-06-25. TRIAL REGISTRATION NUMBER: UMIN000044660. Registration site: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000051004.

Indexed as

Artificial IntelligenceBlepharoptosisHumansMachine LearningNeural Networks, ComputerProspective StudiesArtificial intelligenceAutomatic diagnosisBlepharoptosisConvolutional neural networkTablet device

Identifiers

PMID34734349
OpenAlexW3210323460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.